| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.088 | 0.1 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |